Logo image
Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling
Journal article   Open access   Peer reviewed

Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling

Thomas Edlind, Lamar Smith, Karl Henry, Santosh Katiyar and Joseph Nickels
Molecular microbiology, v 46(1)
Oct 2002
PMID: 12366848
url
https://doi.org/10.1046/j.1365-2958.2002.03165.xView
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

Antifungal Agents - pharmacology Gene Expression Regulation, Fungal Calcium - metabolism Humans Saccharomyces cerevisiae - drug effects Saccharomyces cerevisiae Proteins - genetics Azoles - pharmacology Terbinafine Naphthalenes - pharmacology Calcineurin Inhibitors Egtazic Acid - pharmacology Models, Biological Saccharomyces cerevisiae Proteins - metabolism Tacrolimus - pharmacology Calmodulin - antagonists & inhibitors Calcium Signaling
The most important group of antifungals is the azoles (e.g. miconazole), which act by inhibiting lanosterol demethylase in the sterol biosynthesis pathway. Azole activity can be modulated through structural changes in lanosterol demethylase, altered expression of its gene ERG11, alterations in other sterol biosynthesis enzymes or altered expression of multidrug transporters. We present evidence that azole activity versus Saccharomyces cerevisiae is also modulated by Ca2+-regulated signalling. (i) Azole activity was reduced by the addition of Ca2+. Conversely, azole activity was enhanced by the addition of Ca2+ chelator EGTA. (ii) Three structurally distinct inhibitors (fluphenazine, calmidazolium and a W-7 analogue) of the Ca2+-binding regulatory protein calmodulin enhanced azole activity. (iii) Two structurally distinct inhibitors (cyclosporin and FK506) of the Ca2+-calmodulin-regulated phosphatase calcineurin enhanced azole activity. (iv) Strains in which the Ca2+ binding sites of calmodulin were eliminated and strains in which the calcineurin subunit genes were disrupted demonstrated enhanced azole sensitivity; conversely, a mutant with constitutively activated calcineurin phosphatase demonstrated decreased azole sensitivity. (v) CRZ1/TCN1 encodes a transcription factor regulated by calcineurin phosphatase; its disruption enhanced azole sensitivity, whereas its overexpression decreased azole sensitivity. All the above treatments had comparable effects on the activity of terbinafine, an inhibitor of squalene epoxidase within the sterol biosynthesis pathway, but had little or no effect on the activity of drugs with unrelated targets. (vi) Treatment of S. cerevisiae with azole or terbinafine resulted in transcriptional upregulation of genes FKS2 and PMR1 known to be Ca2+ regulated. A model to explain the role of Ca2+-regulated signalling in azole/terbinafine tolerance is proposed.

Metrics

12 Record Views
102 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Biochemistry & Molecular Biology
Microbiology
Logo image